DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer
NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., Aug. 30, 2022 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced the expansion of its management team by the appointment of Fred Knechtel as Chief Financial…